EQS-News: SCHOTT Pharma IPO: Early termination of stabilization period and full exercise of the Greenshoe Option
Stabilization period ending early on October 6, 2023; Greenshoe Option fully exercised
- Stabilization period ending early on October 6, 2023; Greenshoe Option fully exercised
SCHOTT AG has been informed by BofA Securities Europe SA (BofA), in its role as stabilization manager, that the stabilization period in connection with the initial public offering (IPO) of SCHOTT Pharma concluded early on October 6, 2023. - Given the positive performance of the SCHOTT Pharma shares since listing, no stabilization measures were conducted.
- SCHOTT Glaswerke Beteiligungs- und Export GmbH (a wholly-owned subsidiary of SCHOTT AG – “Selling Shareholder”) will receive gross proceeds of EUR 122 million from the exercise of the Greenshoe Option.
- While we're happy with our achievements so far, we remain dedicated to pursuing our future aspirations.”
In relation to the SCHOTT Pharma IPO, BofA had been authorized to undertake stabilization measures to uphold the market price of SCHOTT Pharma shares.